These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 498703)

  • 1. Plasma levels of chlorimipramine and its demethyl metabolite during treatment of depression.
    Träskman L; Asberg M; Bertilsson L; Cronholm B; Mellström B; Neckers LM; Sjöqvist F; Thorén P; Tybring G
    Clin Pharmacol Ther; 1979 Nov; 26(5):600-10. PubMed ID: 498703
    [No Abstract]   [Full Text] [Related]  

  • 2. Monoamine metabolites in cerebrospinal fluid and serotonin uptake inhibition during treatment with chlorimipramine.
    Asberg M; Ringberger VA; Sjöqvist F; Thorén P; Träskman L; Tuck JR
    Clin Pharmacol Ther; 1977 Feb; 21(2):201-7. PubMed ID: 13959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma concentrations of clomipramine and its N-desmethyl metabolite in depressive patients following treatment with various dosage regimes of clomipramine.
    Jones RB; Luscombe DK
    Postgrad Med J; 1977; 53 Suppl 4():63-76. PubMed ID: 758091
    [No Abstract]   [Full Text] [Related]  

  • 4. Plasma concentration of clomipramine and desmethylclomipramine and clinical response in depressed patients.
    Montgomery SA; McAuley R; Montgomery DB; Dawling S; Braithwaite RA
    Postgrad Med J; 1980; 56 Suppl 1():130-3. PubMed ID: 7393823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clomipramine plasma level and clinical response.
    Broadhurst AD; James HD; Corte LD; Heeley AF
    Postgrad Med J; 1977; 53 Suppl 4():139-45. PubMed ID: 600891
    [No Abstract]   [Full Text] [Related]  

  • 6. Differential effect of chlorimipramine and nortriptyline on cerebrospinal fluid metabolites of serotonin and noradrenaline in depression.
    Bertilsson L; Asberg M; Thorén P
    Eur J Clin Pharmacol; 1974 Aug; 7(5):365-8. PubMed ID: 4420178
    [No Abstract]   [Full Text] [Related]  

  • 7. Plasma levels and clinical improvement--a comparative study of clomipramine and amitriptyline in depression.
    Moyes IC; Ray RL; Moyes RB
    Postgrad Med J; 1980; 56 Suppl 1():127-9. PubMed ID: 7393822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [N-dealkylation of chlorimipramine and chlorpromazine in patients undergoing chronic treatment with both drugs: preliminary results].
    Sgaragli GP; Ninci R; Della Corte L; Borghesi R; Nardini M; Battistini N
    Boll Soc Ital Biol Sper; 1984 Sep; 60(9):1727-33. PubMed ID: 6525292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic chlorimipramine does not reverse the reduction of cerebrospinal fluid Met-enkephalin-like immunoreactivity in chronic-pain patients.
    Bourgoin S; Cesselin F; Gozlan H; Fattaccini CM; Tran MA; Montastruc JL; Rascol A; Hamon M
    Clin Neuropharmacol; 1987 Oct; 10(5):434-42. PubMed ID: 2460234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma level studies with clomipramine (anafranil).
    Jones RB; Luscombe DK
    J Int Med Res; 1977; 5(1 Suppl):98-107. PubMed ID: 863094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central serotonin deficiency--a factor which increases depression vulnerability?
    van Praag HM; de Haan S
    Acta Psychiatr Scand Suppl; 1980; 280():89-96. PubMed ID: 6157306
    [No Abstract]   [Full Text] [Related]  

  • 12. [A GLC assay method for chlorimipramine and its NOR1 and NOR2 derivatives in plasma].
    Megazzini I; Wondrak G; Puliti R; Giovannini MG; Cioni P; Della Corte L; Sgaragli GP
    Boll Soc Ital Biol Sper; 1980 Dec; 56(23):2518-20. PubMed ID: 7470295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A sensitive and specific method for the determination of chlorimipramine and desmethylchlorimipramine in plasma using selected ion monitoring with chemical ionization.
    Lapin A; Karobath M
    Biomed Mass Spectrom; 1980 Nov; 7(11-12):588-91. PubMed ID: 7225541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potentiation of the antidepressant action of clomipramine by tryptophan.
    Walinder J; Skott A; Carlsson A; Nagy A; Bjorn-Erik R
    Arch Gen Psychiatry; 1976 Nov; 33(11):1384-9. PubMed ID: 985049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mass fragmentographic analysis of clomipramine and its mono-demethylated metabolite in human plasma.
    Alfredsson G; Wiesel FA; Fyro B; Sedvall G
    Psychopharmacology (Berl); 1977 Mar; 52(1):25-30. PubMed ID: 403553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myoclonic movements as a side-effect of treatment with therapeutic doses of clomipramine.
    Casas M; Garcia-Ribera C; Alvarez E; Udina C; Queralto JM; Grau JM
    Int Clin Psychopharmacol; 1987 Oct; 2(4):333-6. PubMed ID: 3693873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variation in plasma concentrations of clomipramine and desmethylclomipramine during clomipramine therapy.
    Hullin RP
    Postgrad Med J; 1980; 56 Suppl 1():117-9. PubMed ID: 7190279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma level studies of clomipramine and desmethylclomipramine following intravenous infusions of clomipramine in depressive patients.
    Luscombe DK; Wright J; Jain VK
    Postgrad Med J; 1977; 53 Suppl 4():88-96. PubMed ID: 600900
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of depression with tricyclic drugs--pharmacokinetic and pharmacodynamic aspects.
    Asberg M
    Pharmakopsychiatr Neuropsychopharmakol; 1976 Jan; 9(1):18-26. PubMed ID: 10583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Plasma levels of clomipramine and declomipramine in patients with depression: a study of its correlation with therapeutic efficacy].
    Wargny E; Lamiable D; Havet JM; Denis J; Millart H; Choisy H; Pascalis G
    Ann Med Psychol (Paris); 1986 Apr; 144(4):396-406. PubMed ID: 3813333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.